245 related articles for article (PubMed ID: 23675652)
1. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.
De Vos J; Devoogdt N; Lahoutte T; Muyldermans S
Expert Opin Biol Ther; 2013 Aug; 13(8):1149-60. PubMed ID: 23675652
[TBL] [Abstract][Full Text] [Related]
2. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
3. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
4. Generation of single-domain antibody multimers with three different self-associating peptides.
Wang L; Liu X; Zhu X; Wang L; Wang W; Liu C; Cui H; Sun M; Gao B
Protein Eng Des Sel; 2013 Jun; 26(6):417-23. PubMed ID: 23538432
[TBL] [Abstract][Full Text] [Related]
5. Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
Iezzi ME; Policastro L; Werbajh S; Podhajcer O; Canziani GA
Front Immunol; 2018; 9():273. PubMed ID: 29520274
[TBL] [Abstract][Full Text] [Related]
6. Differential tumor-targeting abilities of three single-domain antibody formats.
Bell A; Wang ZJ; Arbabi-Ghahroudi M; Chang TA; Durocher Y; Trojahn U; Baardsnes J; Jaramillo ML; Li S; Baral TN; O'Connor-McCourt M; Mackenzie R; Zhang J
Cancer Lett; 2010 Mar; 289(1):81-90. PubMed ID: 19716651
[TBL] [Abstract][Full Text] [Related]
7. Emerging site-specific bioconjugation strategies for radioimmunotracer development.
Massa S; Xavier C; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2016 Aug; 13(8):1149-63. PubMed ID: 27116898
[TBL] [Abstract][Full Text] [Related]
8. Single domain antibodies: a new concept for epidermal growth factor receptor and EGFRvIII targeting.
Omidfar K; Shirvani Z
DNA Cell Biol; 2012 Jun; 31(6):1015-26. PubMed ID: 22277093
[TBL] [Abstract][Full Text] [Related]
9. Single-Domain Antibody Theranostics on the Horizon.
Wei W; Younis MH; Lan X; Liu J; Cai W
J Nucl Med; 2022 Oct; 63(10):1475-1479. PubMed ID: 35835579
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.
Harmsen MM; Ackerschott B; de Smit H
Front Immunol; 2024; 15():1346328. PubMed ID: 38352869
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging using Nanobodies: a case study.
Devoogdt N; Xavier C; Hernot S; Vaneycken I; D'Huyvetter M; De Vos J; Massa S; De Baetselier P; Caveliers V; Lahoutte T
Methods Mol Biol; 2012; 911():559-67. PubMed ID: 22886276
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
13. Designer genes: recombinant antibody fragments for biological imaging.
Wu AM; Yazaki PJ
Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
[TBL] [Abstract][Full Text] [Related]
14. Single domain antibodies for the knockdown of cytosolic and nuclear proteins.
Böldicke T
Protein Sci; 2017 May; 26(5):925-945. PubMed ID: 28271570
[TBL] [Abstract][Full Text] [Related]
15. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
Arbabi-Ghahroudi M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
[TBL] [Abstract][Full Text] [Related]
16. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.
Massa S; Vikani N; Betti C; Ballet S; Vanderhaegen S; Steyaert J; Descamps B; Vanhove C; Bunschoten A; van Leeuwen FW; Hernot S; Caveliers V; Lahoutte T; Muyldermans S; Xavier C; Devoogdt N
Contrast Media Mol Imaging; 2016 Sep; 11(5):328-339. PubMed ID: 27147480
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.
Goldman ER; Liu JL; Zabetakis D; Anderson GP
Front Immunol; 2017; 8():865. PubMed ID: 28791022
[TBL] [Abstract][Full Text] [Related]
18. Nanobody-based products as research and diagnostic tools.
De Meyer T; Muyldermans S; Depicker A
Trends Biotechnol; 2014 May; 32(5):263-70. PubMed ID: 24698358
[TBL] [Abstract][Full Text] [Related]
19. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
[TBL] [Abstract][Full Text] [Related]
20. Improving the targeting of therapeutics with single-domain antibodies.
Turner KB; Alves NJ; Medintz IL; Walper SA
Expert Opin Drug Deliv; 2016; 13(4):561-70. PubMed ID: 26689649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
